I. Rojas-Marcos

1.8k total citations
22 papers, 440 citations indexed

About

I. Rojas-Marcos is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, I. Rojas-Marcos has authored 22 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 7 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in I. Rojas-Marcos's work include Autoimmune Neurological Disorders and Treatments (5 papers), Glioma Diagnosis and Treatment (5 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). I. Rojas-Marcos is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (5 papers), Glioma Diagnosis and Treatment (5 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). I. Rojas-Marcos collaborates with scholars based in Spain, France and United States. I. Rojas-Marcos's co-authors include Francesc Graus, Lucinda Aguirre‐Cruz, L. Arribas, Manel Esteller, Gaspar Reynés, Ricardo Yayá, Montse Sánchez‐Céspedes, Mercedes García-Villanueva, Maria F. Paz and Carmen Balañá and has published in prestigious journals such as The Lancet, Brain and Neurology.

In The Last Decade

I. Rojas-Marcos

21 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Rojas-Marcos Spain 9 191 171 167 74 65 22 440
Melissa M. Fraser United States 7 272 1.4× 169 1.0× 107 0.6× 42 0.6× 56 0.9× 7 464
Krzysztof Zakrzewski Poland 13 193 1.0× 196 1.1× 79 0.5× 40 0.5× 108 1.7× 66 514
Alexander Romagna Germany 9 108 0.6× 129 0.8× 68 0.4× 75 1.0× 35 0.5× 28 405
Revital Aricha Israel 13 138 0.7× 120 0.7× 320 1.9× 31 0.4× 31 0.5× 30 603
George J. Snipes United States 10 145 0.8× 99 0.6× 102 0.6× 70 0.9× 20 0.3× 22 462
Hazel Rogers United Kingdom 11 187 1.0× 128 0.7× 54 0.3× 40 0.5× 45 0.7× 16 355
Wafik Zaky United States 12 200 1.0× 271 1.6× 110 0.7× 92 1.2× 38 0.6× 66 461
Astrid Nümann Germany 10 223 1.2× 94 0.5× 181 1.1× 25 0.3× 83 1.3× 13 469
Debbie K. Song United States 11 116 0.6× 96 0.6× 103 0.6× 33 0.4× 44 0.7× 16 345
Alberto Durán-Peña France 9 100 0.5× 272 1.6× 56 0.3× 73 1.0× 77 1.2× 16 426

Countries citing papers authored by I. Rojas-Marcos

Since Specialization
Citations

This map shows the geographic impact of I. Rojas-Marcos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Rojas-Marcos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Rojas-Marcos more than expected).

Fields of papers citing papers by I. Rojas-Marcos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Rojas-Marcos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Rojas-Marcos. The network helps show where I. Rojas-Marcos may publish in the future.

Co-authorship network of co-authors of I. Rojas-Marcos

This figure shows the co-authorship network connecting the top 25 collaborators of I. Rojas-Marcos. A scholar is included among the top collaborators of I. Rojas-Marcos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Rojas-Marcos. I. Rojas-Marcos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mavillard, Fabiola, Emilia Servián‐Morilla, I. Rojas-Marcos, et al.. (2023). Ablation of the carboxy-terminal end of MAMDC2 causes a distinct muscular dystrophy. Brain. 146(12). 5235–5248. 4 indexed citations
2.
Rojas-Marcos, I.. (2019). Distrofias musculares. Medicine - Programa de Formación Médica Continuada Acreditado. 12(76). 4486–4496. 3 indexed citations
3.
Rojas-Marcos, I., Géraldine Picard, Ellen Gelpí, et al.. (2012). Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo-associated paraneoplastic cerebellar degeneration. Neuro-Oncology. 14(4). 506–510. 29 indexed citations
4.
Rojas-Marcos, I., et al.. (2010). Linfoma primario del nervio ciático. Neurología. 25(1). 65–67. 3 indexed citations
5.
Rojas-Marcos, I., et al.. (2010). Primary sciatic nerve lymphoma. Neurología (English Edition). 25(1). 65–67. 2 indexed citations
6.
Rojas-Marcos, I., et al.. (2008). [Frontal cortical infarction and contralateral postural and international tremor].. PubMed. 23(1). 62–4. 4 indexed citations
7.
Rojas-Marcos, I., et al.. (2007). Análisis descriptivo de la demanda de asistencia neurológica ambulatoria en un área sanitaria de Huelva. Revista de Neurología. 44(9). 527–527. 4 indexed citations
8.
Rojas-Marcos, I., et al.. (2007). [Room tilt illusion: a rare symptom of migraine aura].. PubMed. 22(1). 58–60. 5 indexed citations
9.
Rojas-Marcos, I., et al.. (2006). Hypersomnia as presenting symptom of anti-Ma2-associated encephalitis: Case study. Neuro-Oncology. 9(1). 75–77. 25 indexed citations
10.
Bruna, Jordi, Sergio Martínez‐Yélamos, Esther Alonso, et al.. (2005). Meningeal Lymphomatosis as the First Manifestation of Splenic Marginal Zone Lymphoma. International Journal of Hematology. 82(1). 63–65. 8 indexed citations
11.
Tserentsoodol, Nomingerel, et al.. (2005). Localization of Scavenger Receptors Class B (SRBI.1 and SRBI.2) Responsible for Lipid Transport in the Retina. 46(13). 2992–2992. 1 indexed citations
12.
Yayá, Ricardo, Maria F. Paz, I. Rojas-Marcos, et al.. (2005). CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas. Neurochirurgie. 51(1). 51–51. 9 indexed citations
13.
Paz, Maria F., Ricardo Yayá, I. Rojas-Marcos, et al.. (2004). CpG Island Hypermethylation of the DNA Repair Enzyme Methyltransferase Predicts Response to Temozolomide in Primary Gliomas. Clinical Cancer Research. 10(15). 4933–4938. 205 indexed citations
14.
Alam, Shahabuddin, et al.. (2003). Establishment of Stably Transfected Human RPE Cell Lines Over-expressing Oxysterol Binding Proteins. Investigative Ophthalmology & Visual Science. 44(13). 385–385. 1 indexed citations
15.
Rojas-Marcos, I., Audrey Rousseau, Florence Keime-Guibert, et al.. (2003). Spectrum of Paraneoplastic Neurologic Disorders in Women with Breast and Gynecologic Cancer. Medicine. 82(3). 216–223. 78 indexed citations
16.
Rojas-Marcos, I., et al.. (2003). . Medicine. 82(3). 216–223. 8 indexed citations
17.
Bruna, Jordi, I. Rojas-Marcos, Sergio Martínez‐Yélamos, et al.. (2003). Meningeal Carcinomatosis as the First Manifestation of a Transitional Cell Carcinoma of the Bladder. Journal of Neuro-Oncology. 63(1). 63–67. 19 indexed citations
18.
Rojas-Marcos, I., et al.. (2003). Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin. Neurology. 61(7). 1019–1019. 12 indexed citations
19.
Rojas-Marcos, I., et al.. (2002). Cerebellar oedema and sideroblastic anaemia. The Lancet. 360(9350). 2046–2046. 2 indexed citations
20.
Rojas-Marcos, I., et al.. (2000). Síndromes paraneoplásicos en otoneuroftalmología. Revista de Neurología. 31(12). 1206–1206. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026